NO170805C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)-(1,6)-nafthyridiner og optiske isomerer derav - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)-(1,6)-nafthyridiner og optiske isomerer derav

Info

Publication number
NO170805C
NO170805C NO881574A NO881574A NO170805C NO 170805 C NO170805 C NO 170805C NO 881574 A NO881574 A NO 881574A NO 881574 A NO881574 A NO 881574A NO 170805 C NO170805 C NO 170805C
Authority
NO
Norway
Prior art keywords
sulphonyldecahydro
naphythridines
isokino
preparation
therapeutically effective
Prior art date
Application number
NO881574A
Other languages
English (en)
Norwegian (no)
Other versions
NO881574D0 (no
NO170805B (no
NO881574L (no
Inventor
Robin D Clark
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of NO881574D0 publication Critical patent/NO881574D0/no
Publication of NO881574L publication Critical patent/NO881574L/no
Publication of NO170805B publication Critical patent/NO170805B/no
Publication of NO170805C publication Critical patent/NO170805C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO881574A 1987-04-13 1988-04-12 Analogifremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)-(1,6)-nafthyridiner og optiske isomerer derav NO170805C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/037,320 US4791108A (en) 1987-04-13 1987-04-13 Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers

Publications (4)

Publication Number Publication Date
NO881574D0 NO881574D0 (no) 1988-04-12
NO881574L NO881574L (no) 1988-10-14
NO170805B NO170805B (no) 1992-08-31
NO170805C true NO170805C (no) 1992-12-09

Family

ID=21893706

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881574A NO170805C (no) 1987-04-13 1988-04-12 Analogifremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)-(1,6)-nafthyridiner og optiske isomerer derav

Country Status (20)

Country Link
US (1) US4791108A (de)
EP (1) EP0288196B1 (de)
JP (1) JP2527784B2 (de)
KR (1) KR960007864B1 (de)
AT (1) ATE92066T1 (de)
AU (1) AU613610B2 (de)
CA (1) CA1331459C (de)
DE (1) DE3882571T2 (de)
DK (2) DK171106B1 (de)
ES (1) ES2058264T3 (de)
FI (1) FI88162C (de)
HU (2) HU199469B (de)
IE (1) IE60624B1 (de)
IL (1) IL86039A (de)
MX (1) MX11083A (de)
NO (1) NO170805C (de)
NZ (1) NZ224221A (de)
PH (1) PH25961A (de)
PT (1) PT87219B (de)
ZA (1) ZA882562B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886798A (en) * 1987-04-13 1989-12-12 Syntex (U.S.A.) Inc. Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers
US4956365A (en) * 1987-04-13 1990-09-11 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
US4960891A (en) * 1987-04-13 1990-10-02 Syntex (U.S.A.) Inc. Process for the preparation of decahydro-8H-isoquino[2,1-g][1,6]naphthyridine derivatives
GB9012469D0 (en) * 1990-06-05 1990-07-25 Glaxo Group Ltd Medicaments
US5231181A (en) * 1991-03-21 1993-07-27 Syntex (U.S.A.) Inc. Process for the preparation of (8as,12as,13as)-decahydroisoquino ((2,1-g) (1,6)-naphthyridin-8-one derivatives
ZA925324B (en) * 1991-07-17 1994-07-17 Syntex Inc Decahydro-8h-isoquino Ú2,1-g¾ Ú1,6¾naphthyridine and decahydrobenzo Úa¾pyrrolo Ú2,3-e¾quinolizine derivatives
US5229387A (en) * 1991-09-20 1993-07-20 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives
CA2477714C (en) * 2002-03-04 2011-01-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg New cinnamic acid salts, processes for the preparation thereof and use thereof as medicament
CN103387583B (zh) * 2012-05-09 2018-04-13 中国科学院上海药物研究所 二芳基并[a,g]喹嗪类化合物、其制备方法、药物组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953598A (en) * 1972-09-08 1976-04-27 The Upjohn Company Compounds, compositions and methods of use
GB1513824A (en) * 1975-05-22 1978-06-14 Wyeth John & Brother Ltd 1,3,4,6,7,11b-hexahydro-2h-benzo(a)quinolizine derivative
US4353911A (en) * 1979-07-20 1982-10-12 Andre Buzas Indolo(2,3-a)quinolizidines, useful in increasing femoral and vertebral blood flow
CH645653A5 (de) * 1980-08-01 1984-10-15 Ciba Geigy Ag Quaternaere, copolymere, hochmolekulare ammoniumsalze auf acrylbasis, deren herstellung und verwendung als aktive komponente in kosmetischen mitteln.
US4454139A (en) * 1980-08-28 1984-06-12 John Wyeth & Brother, Limited α2 -Adrenoceptor antagonistic benzoquinolizines
GB8302499D0 (en) * 1983-01-29 1983-03-02 Wyeth John & Brother Ltd Benzoquinolizines
US4690928A (en) * 1984-02-02 1987-09-01 Merck & Co., Inc. Substituted hexahydro arylquinolizines as α2 blockers
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility

Also Published As

Publication number Publication date
CA1331459C (en) 1994-08-16
DK84693A (da) 1993-07-15
ZA882562B (en) 1989-12-27
AU1450288A (en) 1988-10-13
NO881574D0 (no) 1988-04-12
NZ224221A (en) 1990-07-26
EP0288196B1 (de) 1993-07-28
IE881097L (en) 1988-10-13
NO170805B (no) 1992-08-31
ATE92066T1 (de) 1993-08-15
ES2058264T3 (es) 1994-11-01
IL86039A (en) 1993-05-13
DE3882571T2 (de) 1994-01-20
NO881574L (no) 1988-10-14
AU613610B2 (en) 1991-08-08
DK199388A (da) 1988-10-14
PT87219A (pt) 1988-05-01
EP0288196A1 (de) 1988-10-26
KR880012601A (ko) 1988-11-28
FI881687A0 (fi) 1988-04-12
HU210349A9 (en) 1995-03-28
PH25961A (en) 1992-01-13
DK84693D0 (da) 1993-07-15
HUT47107A (en) 1989-01-30
JP2527784B2 (ja) 1996-08-28
DE3882571D1 (de) 1993-09-02
PT87219B (pt) 1992-12-31
JPS63277679A (ja) 1988-11-15
US4791108A (en) 1988-12-13
MX11083A (es) 1993-04-01
FI88162B (fi) 1992-12-31
DK199388D0 (da) 1988-04-12
HU199469B (en) 1990-02-28
IL86039A0 (en) 1988-09-30
IE60624B1 (en) 1994-07-27
FI881687A (fi) 1988-10-14
FI88162C (fi) 1993-04-13
KR960007864B1 (ko) 1996-06-13
DK171106B1 (da) 1996-06-10

Similar Documents

Publication Publication Date Title
DE3379222D1 (en) Intermediates for the preparation of omeprazole
NO892058L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzamider.
NO862621L (no) Fremgangsmaate ved fremstilling av pyridonkarboksylsyrederivater.
NO170805C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme sulfonyldecahydro-8h-isokino-(2,1-g)-(1,6)-nafthyridiner og optiske isomerer derav
DK196688A (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
NO861244L (no) Fremgangsmaate ved fremstilling av nye therapeutisk aktive (4.2.01)-bicyclooctanderivater.
ATE98961T1 (de) 1,8-benzonaphthyridinderivate und ihre herstellung.
ES2120483T3 (es) Alcoholes benzilo y benzhidrilo.
CA2007760A1 (fr) Nouveaux derives de benzonaphtyridine-1,8, leur preparation et les compositions qui les contiennent
FI883507A0 (fi) Naftotiazepinderivat och deras framstaellning.
NO903514D0 (no) Imidazolderivat og fremgangsmaate til dets fremstilling.
EP0364254A3 (de) Decahydro-8H-isochino[2,1-g][1,6]naphthyridinderivate und verwandte Verbindungen
ES536139A0 (es) Procedimiento para la preparacion de quinolinonas-4
ES536140A0 (es) Procedimiento para la preparacion de quinolinonas-4